Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermacyd Silver Floral Compatibility Study
NCT00933504Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2009
- Primary completion
- Jul 2009
- Countries
- 1
01
Overview
Phase 3, randomised trial of Dermacyd, sponsored by Sanofi. Primary endpoint: Evaluation of the absence of primary and accumulated dermical irritability and dermical sensitivity by using International Contact Dermatitis Research Group (ICDRG) scale at 6 weeks. Started Jun 2009; status: completed.
02
Drugs
Dermacyd
Beyond the preview
Go deeper on NCT00933504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00933504.